TRex Bio Inc. (NASDAQ: TRXB) Stock Competitors & Peer Comparison
See TRXB's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for TRXB and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TRXB | $14.03 | +0.21% | 116.9M | N/A | N/A | N/A |
| RPRX | $57.78 | +1.49% | 25.6B | 11.01 | $5.25 | +1.63% |
| CORT | $121.19 | +1.33% | 12.8B | 338.69 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| KNSA | $79.24 | -0.68% | 6B | 81.69 | $0.97 | N/A |
| LQDA | $27.67 | +1.06% | 2.5B | 20.20 | $1.37 | N/A |
| PBH | $49.00 | +1.60% | 2.3B | 11.09 | $4.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $16.02 | +0.12% | 963.7M | -6.36 | -$2.52 | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
TRXB vs RPRX Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, RPRX has a market cap of 25.6B. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while RPRX trades at $57.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas RPRX's P/E ratio is 11.01. In terms of profitability, TRXB's ROE is N/A, compared to RPRX's ROE of +0.12%. Regarding short-term risk, TRXB is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
TRXB vs CORT Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, CORT has a market cap of 12.8B. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while CORT trades at $121.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas CORT's P/E ratio is 338.69. In terms of profitability, TRXB's ROE is N/A, compared to CORT's ROE of +0.08%. Regarding short-term risk, TRXB is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
TRXB vs WBA Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas WBA's P/E ratio is -1.64. In terms of profitability, TRXB's ROE is N/A, compared to WBA's ROE of -0.57%. Regarding short-term risk, TRXB is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check WBA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
TRXB vs KNSA Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, KNSA has a market cap of 6B. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while KNSA trades at $79.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas KNSA's P/E ratio is 81.69. In terms of profitability, TRXB's ROE is N/A, compared to KNSA's ROE of +0.14%. Regarding short-term risk, TRXB is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check KNSA's competition here
Liquidia Corporation (NASDAQ: LQDA)
TRXB vs LQDA Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, LQDA has a market cap of 2.5B. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while LQDA trades at $27.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas LQDA's P/E ratio is 20.20. In terms of profitability, TRXB's ROE is N/A, compared to LQDA's ROE of +1.50%. Regarding short-term risk, TRXB is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check LQDA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
TRXB vs PBH Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, PBH has a market cap of 2.3B. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while PBH trades at $49.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas PBH's P/E ratio is 11.09. In terms of profitability, TRXB's ROE is N/A, compared to PBH's ROE of +0.09%. Regarding short-term risk, TRXB is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check PBH's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
TRXB vs HROWL Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas HROWL's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to HROWL's ROE of -1.04%. Regarding short-term risk, TRXB is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
TRXB vs HROWM Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas HROWM's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to HROWM's ROE of -1.04%. Regarding short-term risk, TRXB is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
TRXB vs LTGO Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, LTGO has a market cap of 963.7M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while LTGO trades at $16.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas LTGO's P/E ratio is -6.36. In terms of profitability, TRXB's ROE is N/A, compared to LTGO's ROE of N/A. Regarding short-term risk, TRXB is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check LTGO's competition here
Helus Pharma Inc. (NASDAQ: HELP)
TRXB vs HELP Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, HELP has a market cap of 683.7M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while HELP trades at $11.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas HELP's P/E ratio is -2.65. In terms of profitability, TRXB's ROE is N/A, compared to HELP's ROE of -0.71%. Regarding short-term risk, TRXB is less volatile compared to HELP. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check HELP's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
TRXB vs SVA Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas SVA's P/E ratio is -5.68. In terms of profitability, TRXB's ROE is N/A, compared to SVA's ROE of -0.01%. Regarding short-term risk, TRXB is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
TRXB vs CUVL Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, CUVL has a market cap of 281.4M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while CUVL trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas CUVL's P/E ratio is 12.04. In terms of profitability, TRXB's ROE is N/A, compared to CUVL's ROE of N/A. Regarding short-term risk, TRXB is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check CUVL's competition here
High Tide Inc. (NASDAQ: HITI)
TRXB vs HITI Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, HITI has a market cap of 226.7M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while HITI trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas HITI's P/E ratio is -9.53. In terms of profitability, TRXB's ROE is N/A, compared to HITI's ROE of -0.36%. Regarding short-term risk, TRXB is more volatile compared to HITI. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check HITI's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
TRXB vs CELG-RI Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, CELG-RI has a market cap of 224.7M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while CELG-RI trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to CELG-RI's ROE of N/A. Regarding short-term risk, TRXB is less volatile compared to CELG-RI. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check CELG-RI's competition here
Electra Therapeutics Inc. (NASDAQ: ETRA)
TRXB vs ETRA Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, ETRA has a market cap of 197.7M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while ETRA trades at $9.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas ETRA's P/E ratio is -3.52. In terms of profitability, TRXB's ROE is N/A, compared to ETRA's ROE of N/A. Regarding short-term risk, TRXB is less volatile compared to ETRA. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check ETRA's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
TRXB vs CTOR Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, CTOR has a market cap of 78.9M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while CTOR trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas CTOR's P/E ratio is -1.81. In terms of profitability, TRXB's ROE is N/A, compared to CTOR's ROE of -1.03%. Regarding short-term risk, TRXB is more volatile compared to CTOR. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check CTOR's competition here
Atlantic International Corp. (NASDAQ: ATLN)
TRXB vs ATLN Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, ATLN has a market cap of 68.6M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas ATLN's P/E ratio is -0.68. In terms of profitability, TRXB's ROE is N/A, compared to ATLN's ROE of -83.20%. Regarding short-term risk, TRXB is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check ATLN's competition here
Retension Pharmaceuticals Inc. (NASDAQ: RTSN)
TRXB vs RTSN Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, RTSN has a market cap of 43.7M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while RTSN trades at $11.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas RTSN's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to RTSN's ROE of N/A. Regarding short-term risk, TRXB is less volatile compared to RTSN. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check RTSN's competition here
Rite Aid Corporation (NYSE: RAD)
TRXB vs RAD Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas RAD's P/E ratio is -0.05. In terms of profitability, TRXB's ROE is N/A, compared to RAD's ROE of +2.76%. Regarding short-term risk, TRXB is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
TRXB vs GLTO Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas GLTO's P/E ratio is -1.78. In terms of profitability, TRXB's ROE is N/A, compared to GLTO's ROE of -0.83%. Regarding short-term risk, TRXB is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check GLTO's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
TRXB vs NSRX Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, NSRX has a market cap of 28.6M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while NSRX trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas NSRX's P/E ratio is -4.61. In terms of profitability, TRXB's ROE is N/A, compared to NSRX's ROE of -1.59%. Regarding short-term risk, TRXB is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
TRXB vs SCYX Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, SCYX has a market cap of 25.3M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while SCYX trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas SCYX's P/E ratio is -1.18. In terms of profitability, TRXB's ROE is N/A, compared to SCYX's ROE of -0.21%. Regarding short-term risk, TRXB is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check SCYX's competition here
Cosmos Health Inc. (NASDAQ: COSM)
TRXB vs COSM Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, COSM has a market cap of 17.1M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while COSM trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas COSM's P/E ratio is -0.43. In terms of profitability, TRXB's ROE is N/A, compared to COSM's ROE of -1.19%. Regarding short-term risk, TRXB is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check COSM's competition here
Cerenome, Inc. (NASDAQ: CNSY)
TRXB vs CNSY Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, CNSY has a market cap of 12.3M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while CNSY trades at $1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas CNSY's P/E ratio is -0.43. In terms of profitability, TRXB's ROE is N/A, compared to CNSY's ROE of -3.94%. Regarding short-term risk, TRXB is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check CNSY's competition here
Biofrontera Inc. (NASDAQ: BFRI)
TRXB vs BFRI Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, BFRI has a market cap of 11.8M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while BFRI trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas BFRI's P/E ratio is -1.68. In terms of profitability, TRXB's ROE is N/A, compared to BFRI's ROE of -1.28%. Regarding short-term risk, TRXB is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check BFRI's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
TRXB vs CJJD Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas CJJD's P/E ratio is -0.46. In terms of profitability, TRXB's ROE is N/A, compared to CJJD's ROE of -0.25%. Regarding short-term risk, TRXB is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
TRXB vs SSY Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas SSY's P/E ratio is -2.86. In terms of profitability, TRXB's ROE is N/A, compared to SSY's ROE of -0.09%. Regarding short-term risk, TRXB is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check SSY's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
TRXB vs SCNX Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, SCNX has a market cap of 6.4M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while SCNX trades at $3.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas SCNX's P/E ratio is -1.86. In terms of profitability, TRXB's ROE is N/A, compared to SCNX's ROE of -0.54%. Regarding short-term risk, TRXB is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check SCNX's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
TRXB vs BGMS Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, BGMS has a market cap of 5.4M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while BGMS trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas BGMS's P/E ratio is -0.28. In terms of profitability, TRXB's ROE is N/A, compared to BGMS's ROE of -0.32%. Regarding short-term risk, TRXB is less volatile compared to BGMS. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check BGMS's competition here
POMDOCTOR Ltd (NASDAQ: POM)
TRXB vs POM Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, POM has a market cap of 4.2M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while POM trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas POM's P/E ratio is -0.11. In terms of profitability, TRXB's ROE is N/A, compared to POM's ROE of +0.16%. Regarding short-term risk, TRXB is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check POM's competition here
Eocene Ltd. (NASDAQ: EOCN)
TRXB vs EOCN Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, EOCN has a market cap of 3.4M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while EOCN trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas EOCN's P/E ratio is -0.23. In terms of profitability, TRXB's ROE is N/A, compared to EOCN's ROE of N/A. Regarding short-term risk, TRXB is less volatile compared to EOCN. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check EOCN's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
TRXB vs BFRIW Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, BFRIW has a market cap of 3.2M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while BFRIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas BFRIW's P/E ratio is -0.01. In terms of profitability, TRXB's ROE is N/A, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, TRXB is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check BFRIW's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
TRXB vs PAVS Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, PAVS has a market cap of 3M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while PAVS trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas PAVS's P/E ratio is -0.04. In terms of profitability, TRXB's ROE is N/A, compared to PAVS's ROE of -0.46%. Regarding short-term risk, TRXB is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check PAVS's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
TRXB vs MDVL Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas MDVL's P/E ratio is -0.05. In terms of profitability, TRXB's ROE is N/A, compared to MDVL's ROE of -2.39%. Regarding short-term risk, TRXB is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
TRXB vs ATNFW Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas ATNFW's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, TRXB is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
TRXB vs BGMSP Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, TRXB's ROE is N/A, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, TRXB is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
TRXB vs AZNH Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas AZNH's P/E ratio is 38.35. In terms of profitability, TRXB's ROE is N/A, compared to AZNH's ROE of +0.00%. Regarding short-term risk, TRXB is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
TRXB vs LFLYW Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, TRXB's ROE is N/A, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, TRXB is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check LFLYW's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
TRXB vs PRPH Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, PRPH has a market cap of 126.1K. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while PRPH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas PRPH's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to PRPH's ROE of -13.59%. Regarding short-term risk, TRXB is less volatile compared to PRPH. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check PRPH's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
TRXB vs CPD Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, CPD has a market cap of 0. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas CPD's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to CPD's ROE of N/A. Regarding short-term risk, TRXB is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check CPD's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
TRXB vs OREX Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, OREX has a market cap of 0. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas OREX's P/E ratio is -0.14. In terms of profitability, TRXB's ROE is N/A, compared to OREX's ROE of -0.54%. Regarding short-term risk, TRXB is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check OREX's competition here
POZEN Inc. (NASDAQ: POZN)
TRXB vs POZN Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, POZN has a market cap of 0. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas POZN's P/E ratio is N/A. In terms of profitability, TRXB's ROE is N/A, compared to POZN's ROE of +0.61%. Regarding short-term risk, TRXB is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check POZN's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
TRXB vs IPXL Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas IPXL's P/E ratio is -10.11. In terms of profitability, TRXB's ROE is N/A, compared to IPXL's ROE of -1.16%. Regarding short-term risk, TRXB is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for TRXB.Check IPXL's competition here
Shire plc (NASDAQ: SHPG)
TRXB vs SHPG Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas SHPG's P/E ratio is 11.35. In terms of profitability, TRXB's ROE is N/A, compared to SHPG's ROE of +0.13%. Regarding short-term risk, TRXB is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check SHPG's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
TRXB vs ESRX Comparison October 2026
TRex Bio Inc. (NASDAQ: TRXB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRXB stands at 116.9M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, TRXB is priced at $14.03 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRXB currently has a P/E ratio of N/A, whereas ESRX's P/E ratio is 10.69. In terms of profitability, TRXB's ROE is N/A, compared to ESRX's ROE of +0.26%. Regarding short-term risk, TRXB is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for TRXB.Check ESRX's competition here